Andrew Gottesdiener is a Partner at Venrock, where he invests in Series C stage biotechnology and pharmaceuticals companies in the United States. He serves on the board of Apogee Therapeutics and has invested in companies including Apogee Therapeutics and Lycia Therapeutics. Prior roles include Fellow at InSITE, Summer Associate at McKinsey & Company, Summer Research Fellow at the Howard Hughes Medical Institute, Summer Intern at Rhythm Pharmaceuticals, Research Associate at Weill Cornell Medical College, and Student Researcher at Washington University in St. Louis. Andrew studied at the Joan & Sanford I. Weill Medical College of Cornell University and lives in New York.
Andrew Gottesdiener, Partner @ Venrock. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Andrew Gottesdiener from Venrock. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Andrew
Map your path to Andrew instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Andrew
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.